This issue of Directions in Global Health describes PATH's work to control and prevent diarrheal disease, reach out to young scouts in Kenya and Uganda with HIV/AIDS information, assess the impact of malaria control efforts in Zambia, conduct DHS surveys, and shape HPV vaccine introduction in Peru.

Author: PATH

Publication date: December 2008

Region: Global

Part of series: Directions in Global Health

This special issue of Directions in Global Health highlights PATH’s work to advance technologies to improve global health. Featured technologies include low-cost tests to screen for cervical cancer, a new vaccine to protect against meningitis in Africa, products to prevent diarrheal disease, and Ultra Rice food fortification technology. The issue also includes a summary of PATH’s approach to developing and introducing innovative health technologies.

Publication date: May 2009

Region: Global

Part of series: Directions in Global Health

This issue of Directions in Global Health features PATH’s work to address noncommunicable diseases, such as diabetes and cancer. It also covers efforts to improve health in Kenya, build global and country capacity for influenza control, improve gender equity in China, and integrate health services for better outcomes.

Publication date: December 2011

Region: Global

Part of series: Directions in Global Health

This poster describes the AV Avantage HPV E6 Test and the results from a small clinical pilot study. The AV Avantage HPV E6 Test uses high affinity mAb for the specific capture and detection of high-risk HPV-E6 oncoproteins in a lateral flow–based format. Presented at: 26th International Papillomavirus Conference, July 3, 2010; Montreal, Canada.

Author: Berard-Bergery M, Bisht A, Ho M, et al

Publication date: July 2010

Region: Global

The main objective of the review was to examine the available data on the effectiveness, safety, and acceptability of cryotherapy, and to communicate the evidence base to health professionals and policy makers in developing countries.

Author: Castro W; Gage J; Gaffikin L; Ferreccio C; Sellors J; Sherris J; Blumenthal P

Publication date: 2003

Region: Global

Part of series: Cervical Cancer Prevention: Issues in Depth

This report is a synthesis of the project Evaluating HPV Vaccine Delivery Strategies in Vietnam, which aimed to identify appropriate strategies for human papillomavirus (HPV) vaccine delivery in different geographic and socioeconomic conditions. The report summarizes results of both the implementation and research aspects of the project. The document is available as one large file or as four smaller files for easier downloading.

Publication date: December 2010

Region: Asia

The community facilitator's guide, How Can We Prevent Cervical Cancer? was developed for use by community promotion teams as part of a cervical cancer prevention program in San Mart

Publication date: 2002

Region: Latin America

HPV and cervical cancer

Author: Herdman C

Publication date: 2005

Region: Global

Author: Sherris J; Herdman C; Malloy C

Publication date: 2000

Region: Global

Publication date: 2003

Region: Global

This report summarizes the human papillomavirus (HPV) vaccination program implemented in Uganda by PATH, the Uganda National Expanded Program on Immunization of the Ministry of Health, and the Child Health and Development Centre, through the HPV Vaccines: Evidence for Impact project. HPV vaccine was made available to almost 10,000 girls in select parts of the country. The purpose of the study was to investigate operational issues related to HPV vaccination of young adolescent girls, aimed at identifying effective and cost-effective strategies. This report interprets the results and summarizes helpful lessons for policymakers and program managers, especially those in sub-Saharan Africa, looking to shape their own HPV vaccination programs. To see other reports in this series, visit the RHO Cervical Cancer website.

Publication date: January 2011

Region: Global

Part of series: HPV vaccination project lessons learned reports

This report summarizes the human papillomavirus (HPV) vaccination program implemented in Peru by PATH, Instituto de Investigación Nutricional, and Ministerio de Salud de Peru, Estrategia Sanitaria Nacional de Inmunizaciones through the HPV Vaccines: Evidence for Impact project. HPV vaccine was made available to all girls aged nine years or older in grade 5 in selected parts of the country. The purpose of the study was to investigate operational issues related to HPV vaccination of young adolescent girls, aimed at identifying effective and cost-effective strategies. The publication will be useful for policymakers and program managers around the world, and especially in Latin America, who are designing public-sector HPV vaccination programs. To see other reports in this series, visit the RHO Cervical Cancer website.

Publication date: December 2010

Region: Global

Part of series: HPV vaccination project lessons learned reports

This report summarizes the human papillomavirus (HPV) vaccination program implemented in Vietnam by PATH, the Vietnam National Institute of Hygiene and Epidemiology, and the Vietnam National Center for Health Education and Communication through the HPV Vaccines: Evidence for Impact project. The purpose of the study was to investigate operational issues related to HPV vaccination of young adolescent girls, aimed at identifying effective and cost-effective strategies. This report interprets the results and summarizes helpful lessons for policymakers and program managers, especially those in Southeast Asia, looking to shape their own HPV vaccination programs. To see other reports in this series, visit the RHO Cervical Cancer website.

Publication date: November 2012

Region: Asia

Part of series: HPV vaccination project lessons learned reports

Financing the human papillomavirus (HPV) vaccine and mobilizing resources to support new delivery mechanisms will constitute some of the most significant challenges to achieving widespread HPV vaccination in the developing world. Country decision-makers will need to weigh the value of HPV vaccines against other national health priorities, against other vaccines entering the market, and, for some countries, against expanding coverage of existing vaccines. With these cost and financing obstacles resolved, developing countries would be able to build robust programs to immunize adolescents and thus dramatically reduce the incidence of cervical cancer.

Publication date: December 2007

Region: Global

HPVflash is an email news bulletin that disseminates useful cervical cancer prevention information, including updates on vaccines against the human papillomavirus, to interested persons worldwide. HPVflash emails are emailed only a few times a year.

Publication date: 2013

Region: Global

Part of series: E-newsletters

This document offers practical information to countries that plan to pilot, expand, or scale up human papillomavirus (HPV) vaccination programs. The main focus is on issues specific to HPV vaccination, such as working with a young adolescent target population in school settings and developing community support for HPV vaccination programs.

Publication date: 2011

Region: Global

This paper describes the community focus taken by ACCP projects from 1999 to 2004 in eight countries: El Salvador, India, South Africa, Thailand, Ghana, Kenya, Peru, and Bolivia. We include an overview of the various community involvement strategies that were used to increase screening coverage, and we present lessons learned about how to meet women

Author: Coffey P; Arossi S; Bradley J; Dzuba I; White SC; ACCP Community Involvement Affinity Group

Publication date: 2004

Region: Global

Part of series: Cervical Cancer Prevention: Issues in Depth

This website about PATH’s India country program provides an overview of the program and its featured projects. See other PATH program websites.

Publication date: 2013

Region: Asia

Part of series: PATH's program websites

This fact sheet gives an update regarding the two START project biochemical tests being developed to advance cervical cancer screening.

Author: START Team

Publication date: 2006

Region: Global

This fact sheet summarizes the work being done by PATH to develop two new tests to detect infection with cancer-causing human papillomavirus. Designed by the private sector—in partnership with PATH—for use in low-resource settings, these molecular and biochemical screening tools are an innovative answer to the challenge of preventing cervical cancer in the developing world.

Author: Lim J, Sellors J

Publication date: December 2007

Region: Global